About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Dgat2tm1Far
targeted mutation 1, Bob Farese
MGI:3037903
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Dgat2tm1Far/Dgat2tm1Far involves: 129S4/SvJae * C57BL/6J MGI:3037948


Genotype
MGI:3037948
hm1
Allelic
Composition
Dgat2tm1Far/Dgat2tm1Far
Genetic
Background
involves: 129S4/SvJae * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Dgat2tm1Far mutation (1 available); any Dgat2 mutation (32 available)
phenotype observed in females
phenotype observed in males
N normal phenotype

Small size, shiny skin and necrotic tail of Dgat2tm1Far/Dgat2tm1Far mice

mortality/aging
• mice die 2 to 24 hours after birth, putatively due to inadequate substrates for energy metabolism and impaired permeability barrier function in the skin
• subcutaneous injections of glucose at birth prolongs life for only a few hours
• subcutaneous injections of saline combined with increasing the ambient humidity from 50 to 85% prolongs life for several hours

growth/size/body
• newborns weigh 20% less than wild-type
• reduced size persists after birth
• newborns rapidly lose weight due to increased permeability of skin and consequent fluid loss
• mutants are 15% shorter than wild-type
• 14% reduction in body weight at E18.5
• however, body weight at E12.5 is similar to wild-type

liver/biliary system
• after birth, hepatic glycogen levels decrease and are 67% lower than in wild-type
• triglyceride content is nearly undetectable in fetal and newborn livers

homeostasis/metabolism
• 70-90% lower in newborns
• plasma glucose levels are reduced by 68% in E18.5 mutants
• lower surface body temperature
• skin barrier abnormalities, resulting in dehydration from increased epidermal permeability
• after birth, hepatic glycogen levels decrease and are 67% lower than in wild-type
• reduction in neutral lipid content in the liver and BAT
• content of the skin lipid acylceramide is reduced by more than 60%
• all fatty acid classes are reduced by more than 95% in livers
• free fatty acid levels are reduced in total carcass and in liver
• 70-90% lower in newborns
• content of linoleic acid in free fatty acids in both liver and plasma is reduced 77 and 85%, respectively, and by 60% in cholesterol esters in the liver
• however, phospholipids of livers have similar levels of linoleic acid as wild-type
• reduction in the linoleic acid content of triglycerides and free fatty acids in the skin
• neonatal skin shows a moderate reduction in phosphatidylcholine
• 86% reduction in tissue triglycerides at E12.5
• 93% and 60% reduction in total carcass and BAT triglyceride content, respectively
• lipids of neonatal skin show a 96% reduction in triglyceride content
• 70-90% lower in newborns
• triglyceride content is nearly undetectable in fetal and newborn livers

limbs/digits/tail
• necrosis of the tail develops in mutants that survive for 8-24 hours

behavior/neurological
• mutants rarely suckle

integument
• skin barrier abnormalities, resulting in dehydration from increased epidermal permeability
• effacement of the epidermal rete ridges/papillary projections, leading to a flattened dermo-epidermal interface
• compact orthohyperkeratosis of affected stratum corneum
• the epidermis has reduced numbers of lamellar membranes in the stratum corneum extracellular spaces
• individual lamellar bodies often lack normal contents
• within a few hours after birth, skin appears dry and cracked
• skin lacks elasticity





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/19/2024
MGI 6.24
The Jackson Laboratory